These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11386645

  • 41. Retinoblastoma in Turkey: results from a tertiary care center in Ankara.
    Gündüz K, Köse K, Kurt RA, Süren E, Taçyildiz N, Dinçaslan H, Ünal E, Erden E, Heper AO.
    J Pediatr Ophthalmol Strabismus; 2013; 50(5):296-303. PubMed ID: 23937863
    [Abstract] [Full Text] [Related]

  • 42. [The efficacy of large spot indirect ophthalmoscopy laser alone or combined with systemic chemotherapy in retinoblastoma therapy].
    Liang JH, Cheng Y, Deng X, Yu YY, Li XX.
    Zhonghua Yan Ke Za Zhi; 2016 Oct 11; 52(10):745-748. PubMed ID: 27760646
    [Abstract] [Full Text] [Related]

  • 43. High-frequency ultrasound of anterior segment retinoblastoma.
    Finger PT, Meskin SW, Wisnicki HJ, Albekioni Z, Schneider S.
    Am J Ophthalmol; 2004 May 11; 137(5):944-6. PubMed ID: 15126167
    [Abstract] [Full Text] [Related]

  • 44. Chemoreduction for unilateral retinoblastoma.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ.
    Arch Ophthalmol; 2002 Dec 11; 120(12):1653-8. PubMed ID: 12470138
    [Abstract] [Full Text] [Related]

  • 45. A 20-year audit of retinoblastoma treatment outcomes.
    Gündüz AK, Mirzayev I, Temel E, Ünal E, Taçyıldız N, Dinçaslan H, Köse SK, Özalp Ateş FS, Işık MU.
    Eye (Lond); 2020 Oct 11; 34(10):1916-1924. PubMed ID: 32376976
    [Abstract] [Full Text] [Related]

  • 46. Retinoblastoma presenting as spontaneous hyphema.
    Ruiz-Garcia H, Diez RC.
    Can J Ophthalmol; 2007 Jun 11; 42(3):489. PubMed ID: 17508061
    [No Abstract] [Full Text] [Related]

  • 47. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL, Fandiño AC, Schvartzman E, Raslawski E, Schaiquevich P, Manzitti J.
    Pediatr Blood Cancer; 2014 May 11; 61(5):821-6. PubMed ID: 24243706
    [Abstract] [Full Text] [Related]

  • 48. Residual intraretinal retinoblastoma after chemoreduction failure.
    Hwang CK, Aaberg TM, Chevez-Barrios P, Verner-Cole E, Gombos DS, Paysse E, Chintagumpala M, Gao W, Grossniklaus HE.
    Arch Ophthalmol; 2012 Feb 11; 130(2):246-8. PubMed ID: 22332223
    [No Abstract] [Full Text] [Related]

  • 49. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study.
    Eagle RC.
    Arch Pathol Lab Med; 2009 Aug 11; 133(8):1203-9. PubMed ID: 19653710
    [Abstract] [Full Text] [Related]

  • 50. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2009 Mar 11; 116(3):544-551.e1. PubMed ID: 19157557
    [Abstract] [Full Text] [Related]

  • 51. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W, Kobylarz J, Starzycka M, Dluzniewska A.
    Med Wieku Rozwoj; 2001 Mar 11; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [Abstract] [Full Text] [Related]

  • 52. Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retinoblastoma: a prospective study.
    Chawla B, Sharma S, Sen S, Azad R, Bajaj MS, Kashyap S, Pushker N, Ghose S.
    Ophthalmology; 2012 Apr 11; 119(4):850-6. PubMed ID: 22218144
    [Abstract] [Full Text] [Related]

  • 53. Histopathologic risk factors in retinoblastoma in India.
    Gupta R, Vemuganti GK, Reddy VA, Honavar SG.
    Arch Pathol Lab Med; 2009 Aug 11; 133(8):1210-4. PubMed ID: 19653711
    [Abstract] [Full Text] [Related]

  • 54. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G.
    Med Pediatr Oncol; 2002 Jun 11; 38(6):411-5. PubMed ID: 11984802
    [Abstract] [Full Text] [Related]

  • 55. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma].
    Deng X, Cheng Y, Zhu XM, Linghu DD, Zhao MW, Liang JH.
    Zhonghua Yan Ke Za Zhi; 2020 Sep 11; 56(9):681-687. PubMed ID: 32907301
    [Abstract] [Full Text] [Related]

  • 56. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug 11; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

  • 57. Outcomes of Intra- and Extraocular Retinoblastomas from a Single Institute in South India.
    Shah PK, Narendran V, Kalpana N.
    Ophthalmic Genet; 2015 Aug 11; 36(3):248-50. PubMed ID: 24372404
    [Abstract] [Full Text] [Related]

  • 58. [Available approaches to retinoblastoma therapy--literature review].
    Morawski K, Kulig-Stochmal A, Drychowska-Jęmhorska JJ, Kuhicka-Trząska A, Romanowska-Dixon B.
    Klin Oczna; 2015 Aug 11; 117(1):45-9. PubMed ID: 26349159
    [Abstract] [Full Text] [Related]

  • 59. Treatment of Retinoblastoma in 2015: Agreement and Disagreement.
    Abramson DH, Shields CL, Munier FL, Chantada GL.
    JAMA Ophthalmol; 2015 Nov 11; 133(11):1341-7. PubMed ID: 26378747
    [Abstract] [Full Text] [Related]

  • 60. Choroidal Infiltration by Retinoblastoma: Predictive Clinical Features and Outcome.
    Kaliki S, Tahiliani P, Iram S, Ali MH, Mishra DK, Reddy VA.
    J Pediatr Ophthalmol Strabismus; 2016 Nov 01; 53(6):349-356. PubMed ID: 27537248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.